Seyltx Announces Positive Non-Human Primate (NHP) and Additional In Vivo Data for its Centrally Acting Inhibitor of GluN2B in Chronic Cough, Paving the Way for Optimized Later-Stage Phase 2 Trials ...

The first subset coexpresses the orexigenic (appetite-stimulating) agouti-related peptide and neuropeptide Y (NPY) neurotransmitters, acting as an accelerator in the brain to stimulate feeding.